Two Paths Through the Same Market
FIGS and Gildan Activewear both sell apparel, but they operate in entirely different economic realities – one betting on brand loyalty and direct-to-consumer momentum, the other on manufacturing scale and consistent cash returns to shareholders.
FIGS: Built on Healthcare, Priced for Growth
FIGS carved out its market by selling premium scrubs and medical apparel directly to healthcare workers, bypassing traditional retail channels entirely. That direct-to-consumer model gives the company stronger margin control and richer customer data than most apparel brands its size. It also means FIGS lives and dies by its ability to keep acquiring and retaining customers at a cost that doesn’t eat its margins alive.
The brand has built real loyalty among nurses, physicians, and other clinical professionals – a demographic that is notably income-stable and tends to buy on identity as much as function. Scrubs aren’t an impulse purchase for this crowd; they’re part of a professional identity, which is why FIGS has been able to price above commodity alternatives and hold that pricing. The question for 2026 isn’t whether the product is good. It’s whether growth can continue at a pace that justifies the stock’s valuation.
Direct sales models carry overhead that traditional wholesale doesn’t. FIGS spends heavily on digital marketing, customer acquisition, and brand-building – costs that are visible on the income statement and that compress near-term profitability even when revenue is climbing. Investors in FIGS are effectively paying for a future where those acquisition costs normalize and the customer base matures into a high-retention, lower-cost-to-serve segment. That’s a reasonable bet, but it’s still a bet.
Growth-stage consumer companies like FIGS tend to trade at elevated multiples relative to earnings because the market prices in what the business could look like at scale, not what it looks like today. That dynamic makes FIGS more sensitive to earnings misses, guidance cuts, or any signal that customer growth is decelerating. For investors with a longer horizon and a tolerance for volatility, FIGS offers a differentiated brand in a defensible niche. For investors focused on near-term value, the math is harder to close.
Gildan: Lower Multiples, Steady Cash, Global Scale
Gildan Activewear is a different animal. The company manufactures and sells basic apparel – T-shirts, underwear, activewear, socks – at high volume and low cost, distributing through wholesale channels to retailers, screen printers, and promotional product companies worldwide. It is not a brand that consumers seek out by name at the point of sale. It is a brand that powers the supply chain behind brands they do seek out.
That wholesale, volume-driven model produces something FIGS is still building toward: consistent, predictable cash flow. Gildan has used that cash flow to fund share buybacks and dividends, returning capital to shareholders in a way that growth-stage companies simply can’t afford to do. The lower valuation Gildan trades at compared to FIGS reflects both the slower growth profile and the more commoditized nature of its products – but it also means investors are paying less for each dollar of earnings and cash generation.
Gildan’s manufacturing footprint spans Central America and Bangladesh, giving it a cost structure that competitors find difficult to undercut. Vertical integration – controlling everything from yarn spinning to finished garment – allows the company to manage input costs tightly and respond to margin pressure in ways that asset-light brands cannot. When cotton prices spike or shipping costs rise, Gildan has more levers to pull than a company sourcing finished goods from third-party factories.
The company went through significant management turbulence in 2023 and into 2024, when its board ousted founder Glenn Chamandy, triggered a shareholder revolt, and ultimately reinstated him. That episode raised real questions about governance and strategic direction. With Chamandy back at the helm, the company has returned to a focus on operational efficiency and capital returns – but investors who followed the saga closely know that boardroom stability cannot be assumed as a permanent condition.
For value-oriented investors, Gildan’s combination of low valuation multiples, consistent cash generation, and global manufacturing scale makes it an appealing alternative to higher-multiple consumer names. It won’t post the kind of revenue growth numbers that generate headlines, but it also doesn’t need to. The business model is designed for durability, not velocity. That distinction matters enormously when consumer spending softens or market sentiment turns against growth stocks, as it periodically does. Investors interested in stable consumer holdings may find Gildan fits alongside other blue-chip consumer positions in a defensive portfolio.
Gildan’s revenue base is also geographically diverse in a way that FIGS currently is not. International exposure provides some natural hedge against a slowdown in any single market, while FIGS remains heavily concentrated in North America and is still in the early stages of testing international expansion. That concentration is not a fatal flaw, but it is a risk factor worth pricing in when comparing the two stocks directly.
The Core Trade-Off for 2026
Choosing between FIGS and Gildan ultimately comes down to what kind of return profile an investor is constructing. FIGS offers the potential for significant appreciation if its direct-to-consumer model scales as the company intends – but it demands patience, tolerance for earnings volatility, and confidence in a growth narrative that hasn’t fully played out yet. Gildan offers something closer to a cash-compounding machine: less exciting, trading at a discount to growth peers, but generating real returns through buybacks and dividends while the business quietly hums along at global scale.
Neither stock is obviously mispriced in a way that makes the decision easy. FIGS trades at a premium that requires growth to materialize. Gildan trades at a discount that already bakes in skepticism about its growth ceiling. The unresolved question isn’t which business is better built – it’s which market expectation is more likely to be wrong.
